Первичная сосудистая дисрегуляция и глаукома by Katarzyna Konieczka  et al.
ОРИГИНАЛЬНЫЕ СТАТЬИ
20 1/2015   НАЦИОНАЛЬНЫЙ ЖУРНАЛ ГЛАУКОМА
Abstract
The pathogenesis of glaucomatous optic neuropathy is 
still debated. Ocular blood flow (OBF) in glaucoma patients 
is generally reduced, particularly in patients with progres-
sion of damage in spite of a normal IOP. However, the ques-
tion of whether this OBF reduction is only secondary to the 
damage or whether it is a primary causal factor has remained 
open for a long time. In this review, we try to explain why 
vascular dysregulation contributes to glaucomatous dam-
age. In people with primary vascular dysregulation, the 
autoregulation of ocular perfusion is disturbed. Therefore, 
fluctuations in intraocular pressure (IOP) or blood pressure 
lead to an unstable oxygen supply. This in turn increases 
oxidative stress, particularly in the mitochondria of the optic 
nerve head (ONH). The simultaneous activation of the astro-
cytes leads to altered gene expression, which contributes to 
both tissue remodeling in the ONH and the death of retinal 
ganglion cells. The activated astrocytes produce more metal-
loproteinase degrading the extracellular matrix. This results 
in a remodeling of the extracellular matrix, which is basic 
component of ONH excavation.
KEYWORDS: glaucomatous optic neuropathy, ocular blood 
flow, primary vascular dysregulation, Flammer syndrome.
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Резюме
На сегодняшний день патогенез глаукомной оптической 
нейропатии остается спорным вопросом. Известно, у паци-
ентов с глаукомой, особенно с прогрессирующим пораже-
нием при нормальном уровне внутриглазного давления, 
также наблюдается снижение внутриглазного кровотока. 
Однако вопрос о том, является ли это снижение первич-
ным или вторичным по отношению к общему поврежде-
нию тканей при глаукоме, остается открытым. В данном 
обзоре мы пытаемся описать роль, которую играет сосуди-
стая дисрегуляция при глаукоме. У пациентов с первичной 
сосудистой дисрегуляцией происходит нарушение ауторе-
гуляции перфузии глаза. Возникающие из-за этого пере-
пады внутриглазного и артериального давления приводят 
к нестабильному поступлению кислорода в ткани. Это 
в свою очередь повышает оксидативный стресс, особенно 
в митохондриях диска зрительного нерва. Одновременная 
активация клеток астроглии приводит к изменениям в экс-
прессии генов, что вносит свой вклад как в ремоделиро-
вание тканей диска зрительного нерва, так и в гибель ган-
глионарных клеток сетчатки. Активированные астроциты 
производят больше металлопротеиназы, разрушительно 
действующей на внеклеточный матрикс — главный компо-
нент экскавации диска зрительного нерва.
КЛЮЧЕВЫЕ СЛОВА: глаукомная оптическая нейропа-
тия, внутриглазной кровоток, первичная сосудистая дис-
регуляция, синдром Фламмера.
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T
he pathogenesis of glaucomatous damage, and 
in particular, the role of ocular blood flow (OBF) 
in it has still not been definitely explained. The 
discussion began, when Albrecht von Graefe 
described the glaucomatous excavation of the optic 
nerve head (ONH) in the mid-19th century. That an 
increased intraocular pressure (IOP) increases the 
risk of the initiation and progression of glaucomatous 
damage remains unquestioned. However, it is also 
unquestioned that other factors must play a role as well. 
The role of OBF was, and to some extent still is, very 
controversial. In the past, it was technically difficult to 
measure OBF; nowadays, however, the methodology 
used to accomplish this is quickly improving. We know 
that OBF in glaucoma patients is generally reduced, 
particularly in patients with progression of damage 
in spite of a normal IOP. However, the question of 
whether this OBF reduction is only secondary to the 
damage or whether it is a primary causal factor has 
remained open for a long time. In this review, we focus 
on the role of OBF, and particularly the role of primary 
vascular dysregulation (PVD) [1-3].
What is a glaucomatous damage?
Glaucomatous optic neuropathy (GON) is defined 
as loss of retinal ganglion cells, including their axons, 
combined with tissue remodeling. Together, these 
effects lead to a clinical picture of glaucomatous exca-
vation. Cell loss in the retina and in the corpus genicu-
late nucleus is essential, but not specific for glaucoma, 
as such cell loss also occurs in the context of other di-
seases. On the other hand, tissue remodeling is specific 
to glaucoma. Therefore, we use the term glaucoma to 
describe all diseases, leading to a progressing excava-
tion of the ONH. This means that we define glaucoma 
in a way that is phenomenological and independent 
of etiology. However, we would like to emphasize that 
not all authors define glaucoma in this way. 
The distinction between glaucomatous and a non-
glaucomatous optic atrophy has to do with the beha-
vior of the glia. The glia tolerates hypoxia surprisingly 
well as long as it is stable, that is, the oxygen supply 
is indeed reduced but stable. However, if the oxygen 
supply is unstable, free oxygen radicals are produced 
in the mitochondria. If their production exceeds the 
capacity for their elimination, oxidative stress is the 
result. This, along with others factors, activates glial 
cells, which react sensitively to oxidative stress. The 
activated glial cells contribute decisively to the remode-
ling of the extracellular matrix; in a later phase, they 
die, and the ONH excavates. 
This is in contrast to non-glaucomatous optic atro-
phy, in which the loss of neural cells results in develop-
ment of a glial scar and the ONH turns pale but does not 
excavate. It is known from animal experiments that acti-
vation of astrocytes is a prerequisite for the development 
of glaucomatous damage. The most important glial cells 
in the ONH and in the superficial layer of the retina are 
astrocytes. When activated, not only their gene expres-
sion, but also their morphology is altered. The astro-
cyte processes become more irregular, thereby leading 
to increased light scattering. In the ONH, this results in 
a pale neuroretinal rim. In non-glaucomatous optic 
atrophy, the paleness is much more pronounced due to 
a glia-scar scattering the light. In the retina, the forward 
scatter contributes to a glare perceived by the patient 
and the back scatter to glinting spots seen by the oph-
thalmologist. The latter is best observed when examined 
with red-free light (Fig. 1). The glinting spots occur pre-
dominantly in the early phase of glaucomatous damage 
(in the later phases, the astrocytes are lost), and more 
often in glaucoma patients with a vascular component. 
The altered gene expression of the astrocytes leads 
to the increased production of metalloproteinase and 
thereby to digestion of the extracellular matrix, which 
in turn is a prerequisite for tissue remodeling. 
Activated astrocytes produce more nitric oxide. This 
small, short-lived molecule also diffuses into neighbo-
ring neuronal axons; there, it fuses with superoxide to 
form the very toxic peroxynitrite. The important role of 
oxidative stress raises the question of its cause, as well 
as its link to OBF.
Is the ocular blood flow primarily  
or secondarily reduced?
The vascular system of the eye has the following 
four parts: the anterior segment of the eye, the cho-
roid, the retina, and the ONH. These vascular beds 
distinguish themselves clearly, with respect to both 
Fig. 1. While activated astrocytes are barely visible during 
examination with white light (left), they can be well 
observed (arrows) in red-free light (right). The right and 
left pictures show the same eyes (from [1], with permission)
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the morphology and the physiology of the vessels. 
As already mentioned, we know today that the OBF in 
glaucoma patients is generally reduced in the retina, 
choroid and papilla, as well as in the retroocular ves-
sels. Such a reduction can be secondary — on the one 
hand, a consequence of elevated IOP (above all if the 
autoregulation is disturbed), and on the other, resulting 
from glaucomatous damage, as atrophied tissues do 
not need the same blood supply. However, the question 
is whether there is an additional primary component 
that disturbs the OBF. An elevated IOP cannot be the 
only factor reducing the OBF, because 1) the OBF in 
normal-tension glaucoma (NTG) is even more reduced 
compared to the case in high-tension glaucoma, and 
2) the effect of an elevated IOP is normally compensat-
ed through autoregulation. This indicates that the IOP 
only becomes relevant if it is either strongly elevated 
or if the autoregulation is disturbed. This is indeed the 
case in several forms of glaucoma, particularly NTG.
Primary vascular dysregulation:  
The disturbance of autoregulation
Unfortunately, autoregulation is not consistently 
defined in the literature. We define it here as the ability 
of an organ or part of an organ to maintain the blood 
flow, independent of perfusion pressure. Naturally, 
this ability has limits. Major drops or rises of perfusion 
pressure exceed the capacity of autoregulation. 
The following facts support the argument that 
there is a primary vascular component:
• The blood flow disturbances in glaucoma are not 
limited to the eye, but also occur in other organs, for 
example, in the extremities. In the fingertips of patients, 
especially those with NTG (see chapter “Diagnosis of 
Flammer syndrome”), the blood flow is reduced and 
the reaction to cold provocation is increased (Fig. 2);
• The reduction of OBF mostly precedes glaucoma-
tous optic neuropathy;
• OBF reduction predicts future progression of the 
damage; and 
• Autoregulation is disturbed in glaucoma patients, 
progressing despite normal or normalized IOP. The dis-
turbed autoregulation in these patients also explains 
the correlation between the OBF and the peripheral 
blood flow in such cases. 
Risk factors for the progression  
of glaucomatous optic neuropathy
It is not easy to allocate risk to specific factors, 
as these potential factors interact. We would like explain 
this by taking IOP and blood flow as an example. 
Elevated IOP or low blood pressure are not damaging 
as long as a good regulation of OBF can compensate 
for these factors. However, if the autoregulation is 
disturbed, every fluctuation of IOP or blood pressure 
is immediately translated to OBF fluctuation. In such 
a condition, either the IOP (or blood pressure) or the 
disturbed autoregulation can be seen as the factor cau-
sing the damage. Thus, even more important than the 
individual factors are the interactions between them.
An unstable oxygen supply due to a fluctuating 
blood flow leads to oxidative stress
With regard to OBF, there is an apparent paradox 
that on one hand, certain dysfunction of OBF contri-
butes to the damage, but on the other, atherosclerosis — 
while being a risk factor for IOP elevation — does 
not essentially contribute to GON per se. This can be 
explained in that it is not so much the reduction of OBF 
itself that is a risk factor for GON, but rather the fluctu-
ation of blood flow. OBF fluctuation in turn leads to an 
unstable oxygen supply and thereby to oxidative stress 
(particularly in the mitochondria). Oxidative stress not 
only damages the axons, but also activates astrocytes; 
the astrocytes then increase the secretion of many 
molecules, including metalloproteinases, which con-
tribute to tissue remodeling. Figure 3 shows the typi-
cal appearance of an ONH, in which vascular factors 
Fig. 2. Nailfold capillaroscopy with a cold provocation 
test. a) The nailfold capillaries are observed through 
a microscope, while cold air is supplied by a pipe; b) video 
image of normal blood flow in the capillaries; c) blood flow 
cessation after cold provocation (from [1], with permission)
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have crucially contributed to GON. If an excavation is 
predominantly IOP-dependent, the blood vessels are 
nasally displaced. However, if the excavation is rather 
due to OBF fluctuation, the retinal vessels are only 
slightly nasally displaced. 
Primary vascular dysregulation is the most fre-
quent cause of autoregulation disturbance in glaucoma, 
particularly in NTG. While there are obviously many 
different risk factors for GON, in this article, we focus 
on the role of the PVD.
Vascular dysregulations: Primary  
and secondary types
To adapt to the ever-changing needs of blood sup-
ply, the width of the blood vessel must be permanently 
regulated. Many factors are involved in this regulation, 
particularly the vascular endothelial cells.
Blood flow disturbances are seen in sick vessels 
(e.g., in atherosclerosis or inflammation), but also in 
anatomically healthy vessels. If, despite the normal 
morphology of the blood vessels, their regulation 
cannot adapt to the needs of the tissue, this is called 
a functional vascular dysregulation. This can imply an 
inadequate constriction (vasospasm) or an insufficient 
dilation of an artery, arteriole, or capillary in spite of 
the body’s requirements. Often, a relative constriction 
is combined with a simultaneous inadequate dilation 
in another area of the vascular bed, especially the 
veins. Both phenomena have in common a circulation 
that does not suit the momentary requirement. Such 
vascular dysregulations are often combined with other 
vascular dysfunctions (e.g., barrier dysfunction [3]), as 
well as non-vascular symptoms and signs, as described 
further below. 
We distinguish primary vascular dysregulation 
from secondary vascular dysregulation (SVD). SVD is 
the result of disease in a remote organ. For example, 
blood flow in the ONH can be dysregulated due to 
autoimmune arthritis. In contrast, the PVD is a (pro-
bably inborn) predisposition of anatomically healthy 
vessels to react differently to stimuli.
Fig. 3. Typical IOP-related glaucomatous optic neuropathy 
with vessels shifted to the nasal side of the cup (left). 
In contrast, typical vascular-related glaucomatous optic 
neuropathy with clearly weaker nasal displacement of 
vessels (right)
Primary vascular dysregulation (PVD)
People with PVD react differently (often more 
intensely) to various stimuli like cold and emotional 
or mechanical stress. The consequence is a reversible 
reduced — or sometimes elevated — blood circula-
tion in the corresponding organs or parts of them. In 
the past, the term “vasospastic syndrome” was used 
to describe an undesirable reduction in blood flow 
due to multifocal vasoconstriction. However, the term 
PVD syndrome comprises many additional symptoms 
and signs that may be unrelated to blood flow. Since 
this includes not only vascular aspects, the term PVD 
syndrome was not satisfactory, and a better one was 
required. As Josef Flammer was the first to comprehen-
sively describe this syndrome [1-3], we introduced the 
term Flammer syndrome [4, 5]. 
Symptoms and signs of Flammer syndrome
People with Flammer syndrome (Table 1) exhibit 
numerous symptoms and signs which are indeed not 
specific, but which occur considerably more frequent-
ly than they do in other people. The syndrome can be 
more or less pronounced. 
The most remarkable symptom is cold hands 
(Fig. 4) and/or feet. The extremities can already be 
cold under normal environmental temperatures, but 
will become especially so when provoked by cold or 
vibration, or if the subject is under emotional stress. 
Fig. 4. Thermography of the hand, face, and eye of a person 
without (left) and a person with Flammer syndrome (right) 
recorded at room temperature (from [1], with permission). 
The results are shown in false color. In people with Flammer 
syndrome (right), the surface is colder, that is, we see a 
shift of color from red to blue 
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Fig. 5. Example of a 24-hour blood pressure profile of a person 
without (grey) and of a person with Flammer syndrome (red). 
The arterial hypotension is particularly caused by a reduction 
of sodium reabsorption in the proximal tubules (asterisk) of 
the kidneys (from [1], with permission)
Fig. 6. Sleep onset latency in people with (left) and without 
Flammer syndrome (right). The results are shown with a box 
plots. PVD = primary vascular dysregulation (n=32), controls 
(n=31) (modified after Pache M., Kr uchi K., Cajochen C., 
Wirz-Justice A., Dubler B., Flammer J., Kaiser H.J. (2001) 
Cold feet and prolonged sleep-onset latency in vasospastic 
syndrome. The Lancet, with permission)
Fig. 7. The feeling of thirst in the people with Flammer 
syndrome is reduced due to activation of the endothelin-1/
prostaglandin-E2-axis. This suppresses the thirst center 
in the brain 
Fig. 8. In subjects with Flammer syndrome, odor sensation 
is increased (modified after Mozaffarieh M., Hauenstein D., 
Schoetzau A., Konieczka K., Flammer J. (2010) Smell perception 
in normal tension glaucoma patients. Mol Vis, with permission)
Often (but not obligatory) symptoms and signs
•  Cold hands and/or feet
•  Low blood pressure
•  Low body mass index
•  Reduced feeling of thirst
•  Long sleep onset time
•   Increased sensitivity: increased odor sensation, 
increased pain sensation, increased response  
to certain drugs (e.g., calcium channel blockers,  
beta blockers)
•  Migraine
•  Tinnitus
•   Reversible patches of white and red discoloration  
of the skin 
“Gold standard” for diagnosis:
Blood flow cessation in the capillaries of the finger 
nailfold after standardized cold provocation > 11 seconds
Table 1
Symptoms and signs of Flammer syndrome
The blood pressure is mostly low (Fig. 5), particu-
larly when sleeping or when changing from supine 
to upright position (orthostatic hypotension). Blood 
pressure in these subjects often normalizes in the 
course of life, and is sometimes even high in old age. 
The systemic hypotension in these subjects is among 
other things a result of increased loss of sodium due 
to reduced reabsorption of sodium in the proximal 
tubules of the kidneys; this results from the activation 
of the endothelin-1/prostaglandin-E2-axis. 
The sleep onset time is prolonged (Fig. 6). The rea-
son for this is that initiation of sleep in humans (and 
partly also in animals) is strictly coupled to a certain 
feet temperature. As people with Flammer syndrome 
often have colder feet, they also need longer to warm 
them up to the critical temperature. Moreover, their 
circadian rhythm is often delayed by approximately one 
hour. This means that in the evening, these people fall 
asleep later, also waking up later in the morning. 
The feeling of thirst is reduced in people with Flam-
mer syndrome. This is also the consequence of activa-
tion of the endothelin-1/prostaglandin-E2-axis (Fig. 7). 
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It is therefore not specific, as it can also be observed 
in other conditions with increased plasma levels of 
endothelin, such as in patients with multiple sclerosis. 
Sensitivity in general is increased, including sensitivity 
to smells (Fig. 8) or to certain drugs. Some classes of 
drugs (e.g., calcium channel blockers or systemic beta 
blockers) are badly tolerated at normal doses, but well-
tolerated at very low doses. The major cause for this 
lies in the altered expression of ABC-transport proteins, 
which also transport drugs through the cell membranes. 
Likewise, sensitivity to pain is increased due to the effect 
of endothelin on the peripheral pain threshold.
Vasoconstrictions — as a reaction to cold or psycho-
logical stress — also often appear in the eye. Usually, 
this is relatively harmless, but in rare cases, it even leads 
to retinal artery or vein occlusions. If the vasoconstric-
tion occurs in the ear, the subjects suffer from tinnitus, 
hearing impairment, or even sudden hearing loss. In the 
heart, it manifests mainly in the form of silent ischemia.
Flammer syndrome occurs more often in women 
than in men, academics rather than blue-collar workers, 
slim rather than obese subjects, and Asians rather than 
in Caucasians. It is more frequent in reliable people, as 
well as people suffering from migraine (including retinal 
migraine). In some people with this syndrome, illustra-
tive but completely harmless patches of white and red 
discoloration are seen in the face or in the neck when 
they are under stress. All of these symptoms usually 
decrease with age. People with Flammer syndrome most-
ly have few symptoms as long as they are not exposed 
to trigger factors like cold, emotional and mechanical 
stress, drugs, migraine attacks, hunger, and so on.
Ocular blood flow in Flammer syndrome 
correlates with nailfold blood flow
In the absence of trigger factors, the OBF is gene-
rally normal or only slightly reduced. In healthy people, 
a rise in IOP or dip in blood pressure is balanced 
through the autoregulation of the OBF. In Flam-
mer syndrome, this autoregulation is reduced or even 
absent. Hence, fluctuations of perfusion pressure lead 
to an unstable blood flow, and therefore to a fluctu-
ating oxygen supply, with the abovementioned conse-
quences. Interesting and clinically useful for us is the 
observation that the OBF in people with Flammer 
syndrome — but not in others — is correlated to the 
peripheral blood flow (e.g., in the nailfold; Fig. 2). 
In the absence of autoregulation, systemic factors 
dominate, and this explains the correlation. 
Hemorrhages in the optic nerve head  
and the nailfolds are related
Although optic disc hemorrhages are not specific 
for glaucoma, they are related to the future progres-
sion of damage. Like Flammer syndrome, they occur 
more often in NTG than in high-tension glaucoma and 
in women than in men. Interestingly, the occurrences 
of hemorrhages in the ONH and in the nailfolds are sta-
tistically related. This suggests a systemic cause. While 
such hemorrhages in glaucoma were already described 
more than 100 years ago, their pathogenesis is still 
unclear. We assume that these hemorrhages are not 
a result of a rupture, but rather of a barrier dysfunction 
of blood vessels [3]. 
Involvement of the Flammer syndrome  
in normal-tension glaucoma
Although Flammer syndrome can contribute to 
the development, manifestation, or progression of dif-
ferent systemic and ocular diseases, such as retinal 
artery and vein occlusions, anterior ischemic optic 
neuropathy, Susac syndrome, optic nerve compartment 
syndrome, central serous chorioretinopathy, Leber 
hereditary optic neuropathy, or retinitis pigmentosa 
(see [3]), it has been described mainly in the context of 
glaucoma, especially NTG. The link between Flammer 
syndrome and glaucomatous damage is locally elevated 
oxidative stress, especially in the mitochondria of the 
ONH. As long as the antioxidant mechanisms are not 
overly challenged, people with Flammer syndrome stay 
healthy. However, if the balance is shifted, the oxida-
tive stress leads to tissue damage. Up to a certain level, 
this damage can still be repaired, but if the repair sys-
tem is also overstrained, damage slowly accumulates, 
appearing clinically as GON. 
Diagnosis of Flammer syndrome: The role  
of the patient’s history
In clinical practice, one can diagnose Flammer 
syndrome with a focused patient history and clinical 
examination with fairly good accuracy. If required, 
a suspected case can then be confirmed through addi-
tional elaborate examinations. Among these examina-
tions are the following: capillary microscopy with cold 
provocation, dynamic retinal vessel analysis with flicker 
light stimulation, quantification of gene expression in 
the lymphocytes, and endothelin-1 level in the blood. 
The blood flow cessation in the capillaries of the 
finger nailfold after cold provocation is often consi-
dered the “gold standard” for diagnosis. This exami-
nation is carried out with the help of capillary micro- 
scopy (Fig. 2). If a patient shows a blood flow cessa-
tion of more than 11 seconds in the capillaries after 
standardized cold provocation, this is a clear indication 
of a vascular dysregulation. 
Likewise, a reduced neurovascular coupling is 
typical; this can be observed with a dynamic retinal 
vessel analyzer (DVA). Stimulation of the retina with 
flickering light leads to a dilation of the retinal ves-
sels (both arteries and veins) within seconds. This 
response is reduced (Fig. 9) or even absent in Flammer 
syndrome.
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Also helpful is 24-hour blood pressure monitoring. 
Of particular interest are systemic hypotension, blood 
pressure dips, and increased fluctuations. 
Principally in all these examinations, similar results 
can be found in both non-glaucomatous people with 
Flammer syndrome and in glaucoma patients progress-
ing despite a normal or normalized IOP. Interestingly, 
even the alteration of gene expression in the lympho-
cytes of both these groups is the same or very similar. 
All of this proves that there must be a relationship 
between Flammer syndrome and glaucoma.
Therapy in Flammer syndrome cases:  
The role of magnesium
Flammer syndrome is generally harmless and 
therefore requires no treatment. However, if people 
suffer strongly from their symptoms, or if a related 
disease such as NTG develops, treatment should be con-
sidered. The intensity of the treatment depends on the 
clinical picture. Unfortunately, up to the present, little 
research has been done on therapy for this condition.
We primarily treat patients with magnesium, 
a physiological calcium channel blocker. This reduces 
the vasoconstrictive effect of endothelin-1 and 
improves the regulation of OBF. Indeed, a relatively 
high dose of 10–20 mmol/day is needed, which 
fortunately has almost no side effects. 
If this is not sufficient, we combine magnesium 
with a very low dose of calcium channel blocker, 
preferably nifedipine or amlodipine. Controlled studies 
have shown that calcium channel blockers can even 
improve but particularly stabilize the visual fields of 
NTG patients. A low dose is important for the following 
reasons: 1- low doses already have a good effect on the 
regulation of vessels; 2) these patients have elevated 
drug sensitivity; and 3) in most cases, we do not want 
to further decrease blood pressure. Nevertheless, blood 
pressure should be controlled after the initiation of the 
treatment. In patients with elevated blood pressure, 
the dose of the calcium channel blocker can either be 
increased or the low-dose calcium channel blocker 
can be combined with an ACE inhibitor.
To protect the mitochondria from oxidative stress we 
recommend ginkgo biloba (120 mg of extract per day). 
We further recommend antioxidative nutrition, such as 
green and black tea, coffee, red wine, blue fruits and 
berries, tomatoes, fish [6], and so on. Cocoa (dark cho-
colate) improves the function of the endothelium, and 
thus vascular regulation. Omega-3 fatty acids (prefera-
bly in the form of fish) also improve vascular regulation. 
If the blood pressure is too low, we suggest an 
increase in salt intake. In extreme cases, we prescribe 
a low doses of fludrocortisone (0.1 mg 2x per week). 
Such a mineralocorticoid has fewer side effects than 
glucocorticoids. 
In addition, carbonic anhydrase inhibitors (also 
locally applied) also improve the OBF. The beta 
blocker betaxolol has a calcium channel blocking side 
effect, and is therefore suitable in people with Flammer 
syndrome. 
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Fig. 9. Responses of retinal blood vessels to the flickering light measured with dynamic retinal vessel analyser (DVA) 
(a). Normal responses in healthy subjects (b) and reduced responses in glaucoma patients (c). Red: arteries; blue: veins; 
green: area of normal reaction (from [3], with permission) 
Катажина Конежка и др.
